Synthetic Peptides Identify Promiscuous Human Th1 Cell Epitopes of the Secreted Mycobacterial Antigen MPB70
暂无分享,去创建一个
Harald G. Wiker | F. Oftung | H. Wiker | R. Al-Attiyah | A. Mustafa | F. Shaban | Abu S. Mustafa | Fatema A. Shaban | Raja Al-Attiyah | Fredrik Oftung
[1] Andersen,et al. Comparison of Antigen‐Specific T‐Cell Responses of Tuberculosis Patients using Complex or Single Antigens of Mycobacterium tuberculosis , 1998, Scandinavian journal of immunology.
[2] K. Lundin,et al. HLA‐DR4‐restricted T‐cell epitopes from the mycobacterial 60 000 MW heat shock protein (hsp 60) do not map to the sequence homology regions with the human hsp 60 , 1996, Immunology.
[3] T. Godal,et al. In vitro induction of human suppressor T cells by mycobacterial antigens. BCG activated OKT4+ cells mediate suppression of antigen induced T cell proliferation. , 1983, Clinical and Experimental Immunology.
[4] H. Vordermeier,et al. Toward the development of diagnostic assays to discriminate between Mycobacterium bovis infection and bacille Calmette-Guérin vaccination in cattle. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[5] A. Mustafa. Restoration of proliferative response to M. leprae antigens in lepromatous T cells against candidate antileprosy vaccines. , 1996, International journal of leprosy and other mycobacterial diseases.
[6] T. Godal,et al. BCG induced CD4+ cytotoxic T cells from BCG vaccinated healthy subjects: relation between cytotoxicity and suppression in vitro. , 1987, Clinical and experimental immunology.
[7] P. Andersen. Host Responses and Antigens Involved in Protective Immunity to Mycobacterium tuberculosis , 1997, Scandinavian journal of immunology.
[8] K. Lundin,et al. Human T cells recognize mycobacterial heat shock proteins in the context of multiple HLA-DR molecules: studies with healthy subjects vaccinated with Mycobacterium bovis BCG and Mycobacterium leprae , 1993, Infection and immunity.
[9] T. Ottenhoff,et al. Detection of active tuberculosis infection by T cell responses to early-secreted antigenic target 6-kDa protein and culture filtrate protein 10. , 2000, The Journal of infectious diseases.
[10] K. Lukacs,et al. Protection against Mycobacterium tuberculosisInfection by CD8+ T Cells Requires the Production of Gamma Interferon , 1998, Infection and Immunity.
[11] S. Haga,et al. Comparative studies with various substrains of Mycobacterium bovis BCG on the production of an antigenic protein, MPB70 , 1983, Infection and immunity.
[12] Zhu,et al. 38 000 MW antigen‐specific major histocompatibility complex class I restricted interferon‐γ‐secreting CD8+ T cells in healthy contacts of tuberculosis , 1998, Immunology.
[13] F. Oftung,et al. Characteristics of human T-cell clones from BCG and killedM. lepraevaccinated subjects and tuberculosis patients , 1986 .
[14] N. Ohara,et al. Cloning and Sequencing of a Unique Antigen MPT70 from Mycobacterium tuberculosis H37Rv and Expression in BCG Using E. coli‐Mycobacteria Shuttle Vector , 1995, Scandinavian journal of immunology.
[15] M. Levin,et al. Evaluation of human antimycobacterial immunity using recombinant reporter mycobacteria. , 2000, The Journal of infectious diseases.
[16] R. Houghten,et al. Epitopes of the Mycobacterium tuberculosis 65-kilodalton protein antigen as recognized by human T cells. , 1988, Journal of immunology.
[17] J. Flynn,et al. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection , 1993, The Journal of experimental medicine.
[18] J. Flynn,et al. CD4+ T Cells Are Required for the Development of Cytotoxic CD8+ T Cells During Mycobacterium tuberculosis Infection1 , 2001, The Journal of Immunology.
[19] K. Lundin,et al. Primary Structure and MHC Restriction of Peptide-Defined T Cell Epitopes from Recombinant Mycobacterial Protein Antigens , 1997 .
[20] C. Dye,et al. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. , 1999, JAMA.
[21] J. Deeks,et al. Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells , 2001, The Lancet.
[22] J. Matsumoto,et al. Specific skin-reactive protein from culture filtrate of Mycobacterium bovis BCG , 1981, Infection and immunity.
[23] K. Lundin,et al. Heterogeneity among human T cell clones recognizing an HLA-DR4,Dw4-restricted epitope from the 18-kDa antigen of Mycobacterium leprae defined by synthetic peptides. , 1990, Journal of Immunology.
[24] K. Lundin,et al. Identification and HLA Restriction of Naturally Derived Th1-Cell Epitopes from the Secreted Mycobacterium tuberculosisAntigen 85B Recognized by Antigen-Specific Human CD4+T-Cell Lines , 2000, Infection and Immunity.
[25] H. Billman-Jacobe,et al. Differential T cell responses to mycobacteria-secreted proteins distinguish vaccination with bacille Calmette-Guérin from infection with Mycobacterium tuberculosis. , 1994, The Journal of infectious diseases.
[26] T. Ottenhoff,et al. Mycobacteria induce CD4+ T cells that are cytotoxic and display Th1‐like cytokine secretion profile: Heterogeneity in cytotoxic activity and cytokine secretion levels , 1993, European journal of immunology.
[27] M. Torres,et al. Cytokine Profiles for Peripheral Blood Lymphocytes from Patients with Active Pulmonary Tuberculosis and Healthy Household Contacts in Response to the 30-Kilodalton Antigen ofMycobacterium tuberculosis , 1998, Infection and Immunity.
[28] K. Lundin,et al. An HLA-DRw53-restricted T-cell epitope from a novel Mycobacterium leprae protein antigen important to the human memory T-cell repertoire against M. leprae , 1994, Infection and immunity.
[29] J. Abrams,et al. Cytokine production at the site of disease in human tuberculosis , 1993, Infection and immunity.
[30] Melinda Fitzgerald,et al. Immunol. Cell Biol. , 1995 .
[31] H. Wiker,et al. Isolation and partial characterization of major protein antigens in the culture fluid of Mycobacterium tuberculosis , 1991, Infection and immunity.
[32] A. Sette,et al. Differential effects of cytolytic T cell subsets on intracellular infection. , 1997, Science.
[33] P. Andersen,et al. Efficient protection against Mycobacterium tuberculosis by vaccination with a single subdominant epitope from the ESAT‐6 antigen , 2000, European journal of immunology.
[34] J. Pollock,et al. Identification of bovine T-cell epitopes for three Mycobacterium bovis antigens: MPB70, 19,000 MW and MPB57. , 1994, Immunology.
[35] M. Bonneville,et al. Vγ9 / Vδ2 T lymphocytes reduce the viability of intracellular Mycobacterium tuberculosis , 2000 .
[36] M. Harboe,et al. MPB70, a unique antigen of Mycobacterium bovis BCG. , 1984, The American review of respiratory disease.
[37] R. Wilkinson,et al. High frequencies of circulating IFN‐γ‐secreting CD8 cytotoxic T cells specific for a novel MHC class I‐restricted Mycobacterium tuberculosis epitope in M. tuberculosis‐infected subjects without disease , 2000 .
[38] F. Oftung,et al. Characteristics of human T-cell clones from BCG and killed M. leprae vaccinated subjects and tuberculosis patients. Recognition of recombinant mycobacterial antigens. , 1986, Leprosy Review.
[39] P. Dierckx,et al. Specific Lymphoproliferation, Gamma Interferon Production, and Serum Immunoglobulin G Directed against a Purified 32 kDa Mycobacterial Protein Antigen (P32) in Patients with Active Tuberculosis , 1988, Scandinavian journal of immunology.
[40] H. Billman-Jacobe,et al. Mapping of the T and B cell epitopes of the Mycobacterium bovis protein, MPB70 , 1990, Immunology and cell biology.
[41] H. Vordermeier,et al. Development of Diagnostic Reagents To Differentiate between Mycobacterium bovis BCG Vaccination and M. bovis Infection in Cattle , 1999, Clinical Diagnostic Laboratory Immunology.
[42] Pollock,et al. T‐Cell Recognition of Mycobacterial Proteins MPB70 and MPB64 in Cattle Immunized with Antigen and Infected with Mycobacterium bovis , 1998, Scandinavian journal of immunology.
[43] H. Mollenkopf,et al. Differential T cell responses to Mycobacterium tuberculosis ESAT6 in tuberculosis patients and healthy donors , 1998, European journal of immunology.
[44] A. Mustafa,et al. HLA-DR-restricted antigen-induced proliferation and cytotoxicity mediated by CD4+ T-cell clones from subjects vaccinated with killed M. leprae. , 1989, International journal of leprosy and other mycobacterial diseases.
[45] P. E. M. Fine,et al. Variation in protection by BCG: implications of and for heterologous immunity , 1995, The Lancet.
[46] H. Wiker,et al. Protein G-based enzyme-linked immunosorbent assay for anti-MPB70 antibodies in bovine tuberculosis , 1990, Journal of clinical microbiology.
[47] T. Yamada,et al. Complete nucleotide sequence of immunogenic protein MPB70 from Mycobacterium bovis BCG. , 1989, FEMS microbiology letters.
[48] N. Kudeken,et al. [A therapeutic trial of experimental tuberculosis with gamma-interferon in an immunocompromised mouse model]. , 1994, Kekkaku : [Tuberculosis].
[49] A. Mustafa. Biotechnology in the development of new vaccines and diagnostic reagents against tuberculosis. , 2001, Current pharmaceutical biotechnology.
[50] H. Vordermeier,et al. Immunogenicity of Mycobacterium tuberculosis RD1 region gene products in infected cattle , 2002, Clinical and experimental immunology.
[51] T. Eguale,et al. Human T cell responses to the ESAT-6 antigen from Mycobacterium tuberculosis. , 1999, The Journal of infectious diseases.
[52] M. Gennaro,et al. Immunochemical Characterization of the MPB70/80 and MPB83 Proteins of Mycobacterium bovis , 1998, Infection and Immunity.
[53] T. Ottenhoff,et al. Mapping of multiple HLA class II-restricted T-cell epitopes of the mycobacterial 70-kilodalton heat shock protein , 1994, Infection and immunity.
[54] G. Kvalheim,et al. Mycobacterial crossreactivity of M. tuberculosis reactive T cell clones from naturally converted PPD positive healthy subjects. , 1998, FEMS immunology and medical microbiology.
[55] A. Mustafa. Identification of T-cell-activating recombinant antigens shared among three candidate antileprosy vaccines, killed M. leprae, M. bovis BCG, and mycobacterium w. , 1988, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association.
[56] K. Lundin,et al. Identification of Promiscuous Epitopes from the Mycobacterial 65-Kilodalton Heat Shock Protein Recognized by Human CD4+ T Cells of the Mycobacterium lepraeMemory Repertoire , 1999, Infection and Immunity.
[57] J. Abrams,et al. Cytokine secretion by CD4 T lymphocytes acquired in response to Mycobacterium tuberculosis infection. , 1993, Journal of immunology.
[58] O. Olerup,et al. DR "low-resolution" PCR-SSP typing--a correction and an up-date. , 1993, Tissue antigens.
[59] A. Hill,et al. Enumeration of T cells specific for RD1-encoded antigens suggests a high prevalence of latent Mycobacterium tuberculosis infection in healthy urban Indians. , 2001, The Journal of infectious diseases.
[60] K. Hasløv,et al. Development of the Mycobacterium bovis BCG vaccine: review of the historical and biochemical evidence for a genealogical tree. , 1999, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[61] T. Hansen,et al. Pathway of propionate degradation in Desulfobulbus propionicus , 1988 .
[62] T. Lea,et al. T‐ and B‐Cell Epitopes in the Secreted Mycobacterium bovis Antigen MPB70 in Mice , 2003, Scandinavian journal of immunology.